OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

Abivax S.A.

CIK 0001956827Ticker AAVXFSEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Open issuer dossier
Reporting & material events38

captured official filings

Registration & offering12

captured official filings

Ownership6

captured official filings

Governance0

captured official filings

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing F-1/A filed 2023-10-16 with F-1/A filed 2023-10-18.

Earlier SEC filingLatest SEC filing
368latest comparable sentences
13new-text candidates
11prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • shares107 → 101-6
  • offering72 → 67-5
  • proceeds13 → 15+2
  • control33 → 34+1

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • SUBJECT TO COMPLETION, DATED OCTOBER 18, 2023 PRELIMINARY PROSPECTUS 20,325,500 Ordinary Shares (Including Ordinary Shares in the Form of American Depositary Shares) €    per Ordinary Share
    DOWNLOAD EDITION

    Save a project-ready issuer record.

    US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.

    • Source-linked filing chronology and registration path
    • Machine-detected amendment and tracked-term change view
    • Official-source index for project-file archiving and downloadable CSV export

    Secure checkout by PayPal.

    AUTOMATED EVIDENCE SNAPSHOT

    Save this source-linked record

    Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

    Unlock download · US$29
    amp;#8195;   per American Depositary Share We are offering an aggregate of 20,325,500 ordinary shares in a
  • On October 18, 2023, the last reported closing price of our ordinary shares on Euronext Paris was €11.84 per ordinary share, equivalent to a price of $12.51 per ADS, assuming an exchange rate of €0.9465 per U.S. dollar, the exchange rate on October 18, 2023 as reported by the European Central Bank.
  • We have granted an option to the underwriters, exercisable within 30 days from the date of this prospectus, to purchase up to an aggregate of 3,048,825 additional ADSs and/or ordinary shares (representing up to 15% of the initial size of the global offering) in the global offering to be sold to the several underwriters at the ap
Present in earlier filing, not found in latest
  • SUBJECT TO COMPLETION, DATED OCTOBER 16, 2023 PRELIMINARY PROSPECTUS 18,675,500 Ordinary Shares (Including Ordinary Shares in the Form of American Depositary Shares) €    per Ordinary Share
    amp;#8195;   per American Depositary Share We are offering an aggregate of 18,675,500 ordinary shares in a
  • However, in accordance with French law and the shareholders’ resolutions applicable to this offering, such prices will not be lower than 10% below the volume-weighted average price of our ordinary shares on Euronext Paris for the three trading days preceding the appropriate reference date.
  • On October 13, 2023, the last reported closing price of our ordinary shares on Euronext Paris was €12.72 per ordinary share, equivalent to a price of $13.39 per ADS, assuming an exchange rate of €0.9502 per U.S. dollar, the exchange rate on October 13, 2023 as reported by the European Central Bank.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 6-K
    Reporting & material eventsOpen SEC filing →
  2. 424B5
    Registration & offeringOpen SEC filing →
  3. 424B5
    Registration & offeringOpen SEC filing →
  4. 6-K
    Reporting & material eventsOpen SEC filing →
  5. 6-K
    Reporting & material eventsOpen SEC filing →
  6. 6-K
    Reporting & material eventsOpen SEC filing →
  7. 6-K
    Reporting & material eventsOpen SEC filing →
  8. 6-K
    Reporting & material eventsOpen SEC filing →
  9. 424B7
    Registration & offeringOpen SEC filing →
  10. 6-K
    Reporting & material eventsOpen SEC filing →
  11. 20-F
    Reporting & material eventsOpen SEC filing →
  12. 6-K
    Reporting & material eventsOpen SEC filing →
  13. 6-K
    Reporting & material eventsOpen SEC filing →
  14. 6-K
    Reporting & material eventsOpen SEC filing →
  15. 6-K
    Reporting & material eventsOpen SEC filing →
  16. 424B5
    Registration & offeringOpen SEC filing →
  17. 6-K
    Reporting & material eventsOpen SEC filing →
  18. 424B5
    Registration & offeringOpen SEC filing →
  19. 6-K
    Reporting & material eventsOpen SEC filing →
  20. 6-K
    Reporting & material eventsOpen SEC filing →
  21. 6-K
    Reporting & material eventsOpen SEC filing →
  22. 6-K
    Reporting & material eventsOpen SEC filing →
  23. 6-K
    Reporting & material eventsOpen SEC filing →
  24. 20-F
    Reporting & material eventsOpen SEC filing →
  25. 6-K
    Reporting & material eventsOpen SEC filing →
  26. 6-K
    Reporting & material eventsOpen SEC filing →
  27. 6-K
    Reporting & material eventsOpen SEC filing →
  28. EFFECT
    Registration & offeringOpen SEC filing →
  29. 6-K
    Reporting & material eventsOpen SEC filing →
  30. 6-K
    Reporting & material eventsOpen SEC filing →
  31. SC 13G/A
    OwnershipOpen SEC filing →
  32. 6-K
    Reporting & material eventsOpen SEC filing →
  33. 6-K
    Reporting & material eventsOpen SEC filing →
  34. 6-K
    Reporting & material eventsOpen SEC filing →
  35. 6-K
    Reporting & material eventsOpen SEC filing →
  36. 6-K
    Reporting & material eventsOpen SEC filing →
  37. 6-K
    Reporting & material eventsOpen SEC filing →
  38. 6-K
    Reporting & material eventsOpen SEC filing →
  39. 6-K
    Reporting & material eventsOpen SEC filing →
  40. 6-K
    Reporting & material eventsOpen SEC filing →
  41. 6-K
    Reporting & material eventsOpen SEC filing →
  42. SC 13G
    OwnershipOpen SEC filing →
  43. 20-F
    Reporting & material eventsOpen SEC filing →
  44. 6-K
    Reporting & material eventsOpen SEC filing →
  45. SC 13G/A
    OwnershipOpen SEC filing →
  46. 6-K
    Reporting & material eventsOpen SEC filing →
  47. 6-K
    Reporting & material eventsOpen SEC filing →
  48. SC 13G
    OwnershipOpen SEC filing →
  49. SC 13G
    OwnershipOpen SEC filing →
  50. SC 13D
    OwnershipOpen SEC filing →
  51. 424B4
    Registration & offeringOpen SEC filing →
  52. EFFECT
    Registration & offeringOpen SEC filing →
  53. EFFECT
    Registration & offeringOpen SEC filing →
  54. F-1/A
    Registration & offeringOpen SEC filing →
  55. F-1/A
    Registration & offeringOpen SEC filing →
  56. F-1
    Registration & offeringOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.